Concord Biotech Limited announced its first-ever 1:1 bonus issue, approved by its board on September 23. The stock rose nearly 2%, reflecting investor interest
Read more at the source
Disclaimer: The content of this post is sourced from external sites and is for informational purposes only. All rights and credits belong to the original authors and publishers.